Oxyntomodulin inhibits gastric acid secretion via its C-terminal octap
eptide. Its minimal active structure was delineated by testing, on his
tamine-stimulated gastric acid secretion in the conscious rat, the inh
ibitory effect of octapeptide analogues, shortened either or both on t
heir N- or C-terminus. The octapeptide may be simplified by deleting t
he two C-terminal amino acids while keeping its efficacy and the slope
of the dose-response curve. Suppressing the first N-terminal amino ac
id dramatically decreased the activity. The nonprotected peptides are
metabolized by aminopeptidases and endopeptidases. The increased poten
cy of the N-acetylated forms is related, at least in part, with their
protection against aminopeptidases.